Sanatorium profesora Arenbergera

The site conducts research in immune system diseases, focusing on conditions such as alopecia areata. Trials aim to assess the long‑term safety and tolerability of novel agents, providing valuable data for future therapeutic options.

• Evaluation of PF-06651600 in alopecia areata
• Long‑term safety assessment of emerging immune therapies

Through these studies, Sanatorium profesora Arenbergera contributes to advancing care for patients with autoimmune hair loss, supporting the development of safer, more effective treatments.

Research at the centre includes skin and connective tissue diseases, with a particular emphasis on moderate-to-severe plaque psoriasis. The objective is to characterize the safety profile of innovative treatments over extended periods.

• Characterization of BMS-986165 safety in plaque psoriasis
• Extended efficacy monitoring in severe psoriasis

These investigations at Sanatorium profesora Arenbergera help refine therapeutic strategies for psoriasis, aiming to improve patient outcomes and quality of life.